Syngene International Ltd Hits Intraday Low Amid Price Pressure

Intraday Performance and Price Movement

On 23 Jan 2026, Syngene International Ltd opened sharply lower, down 2.08% from the previous close, signalling immediate selling pressure. The stock continued to weaken throughout the trading session, touching an intraday low of Rs 546.8, marking a decline of 7.66% from its previous close. This intraday low also represents a new 52-week low for the stock, underscoring the extent of the current downtrend.

The day’s decline of 7.77% notably outpaced the Sensex’s fall of 0.87%, reflecting a pronounced underperformance relative to the broader market. Syngene’s intraday drop was also 6.57% worse than the Healthcare Services sector’s performance, indicating sector-specific headwinds exacerbating the stock’s weakness.

Technical Indicators and Moving Averages

Technically, Syngene International Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This broad-based technical weakness signals sustained downward momentum and a lack of near-term support levels. The stock’s failure to hold above these averages suggests that selling interest remains dominant among market participants.

Moreover, the stock has been on a consistent downward trajectory, recording losses for eight consecutive trading sessions. Over this period, Syngene has declined by 13.59%, a stark contrast to the Sensex’s modest 2.39% fall during the same timeframe. This extended slide highlights persistent selling pressure and a challenging market environment for the company.

Comparative Performance Analysis

Syngene International Ltd’s recent performance metrics reveal a sustained underperformance relative to the benchmark indices. The stock’s one-day decline of 8.11% far exceeds the Sensex’s 0.89% drop. Over one week, the stock has fallen 13.24%, compared to the Sensex’s 2.39% decline. The one-month and three-month returns show similar trends, with Syngene down 17.37% and 17.85% respectively, while the Sensex has declined by 4.62% and 3.52% over the same periods.

Year-to-date, Syngene has lost 16.41%, significantly underperforming the Sensex’s 4.28% fall. Over the longer term, the stock’s three-year and five-year returns remain negative at -9.95% and -6.94%, respectively, while the Sensex has delivered robust gains of 33.86% and 66.90% over the same durations. Even the ten-year performance, though positive at 174.38%, trails the Sensex’s 233.84% appreciation, indicating a relative lag in value creation for shareholders.

Market Sentiment and Sector Context

The broader market environment on 23 Jan 2026 was characterised by negative sentiment. The Sensex, after opening flat with a marginal gain of 28.57 points, declined sharply by 744.91 points to close at 81,591.03, a fall of 0.87%. The index is trading below its 50-day moving average, although the 50-day average remains above the 200-day average, suggesting some medium-term support for the market overall.

Within the sector, the NIFTY Realty index also hit a new 52-week low, indicating sector-wide pressures that may be influencing investor sentiment towards related stocks, including Syngene International Ltd. The Healthcare Services sector’s underperformance relative to the broader market further compounds the challenges faced by Syngene today.

Mojo Score and Ratings Update

Syngene International Ltd currently holds a Mojo Score of 28.0, categorised as a Strong Sell. This rating was upgraded from Sell to Strong Sell on 19 Jan 2026, reflecting a deterioration in the company’s overall quality and market standing. The Market Cap Grade stands at 3, indicating a mid-tier market capitalisation relative to peers. These ratings align with the observed price weakness and technical deterioration, signalling caution among market participants.

Summary of Price Pressure Drivers

The sharp decline in Syngene International Ltd’s share price today can be attributed to a combination of factors. The stock’s extended losing streak over the past eight sessions has eroded investor confidence, while its technical positioning below all major moving averages signals ongoing weakness. The broader market’s negative tone, coupled with sector-specific underperformance, has intensified selling pressure.

Additionally, the downgrade to a Strong Sell rating and the low Mojo Score reflect a challenging outlook for the stock’s near-term performance. The new 52-week low reached today underscores the absence of immediate support, suggesting that the stock remains vulnerable to further declines in the short term.

Conclusion

Syngene International Ltd’s intraday low of Rs 546.8 on 23 Jan 2026 highlights the prevailing price pressure and negative market sentiment surrounding the stock. The combination of technical weakness, sector headwinds, and broader market declines has contributed to the stock’s underperformance relative to the Sensex and its peers. Investors and market watchers will note the sustained downward trend and the recent rating downgrade as key indicators of the stock’s current challenges.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →